ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR
· Real-Time Price · USD
2.04
0.02 (0.99%)
At close: Aug 15, 2025, 3:59 PM
2.05
0.24%
After-hours: Aug 15, 2025, 04:10 PM EDT
ProQR Therapeutics Cash Flow Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -30.2M | -27.82M | -23.86M | -21.17M | -26.44M | -27.59M | -33.64M | -52.6M | -59.3M | -64.89M | -71.74M | -62.43M | -63.51M | -61.68M | -56.67M | -54.79M | -43.15M |
Depreciation & Amortization | 2.75M | 2.76M | 2.8M | 2.75M | 2.64M | 2.49M | 2.53M | 2.5M | 2.5M | 2.52M | 2.33M | 2.26M | 2.27M | 2.33M | 2.43M | 2.54M | 2.46M |
Stock-Based Compensation | 2.57M | 2.54M | 2.78M | 2.61M | 2.75M | 3.11M | 1.92M | 2.81M | 2.78M | 2.87M | 5.04M | 5.42M | 6.15M | 6.22M | 5.92M | 5.88M | 6.22M |
Other Working Capital | -10.76M | -13.26M | -10.43M | -13.55M | -12.56M | -3.33M | -5.63M | -3.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | -1.21M | -460.38K | -3.1M | -4.21M | -4.71M | -5.38M | -3.05M | 1.57M | -204K | -3.57M | -2.2M | -5.65M | -1.57M | 2.47M | 3.83M | 5.61M | -3.85M |
Deferred Income Tax | -200K | -197K | -192K | -275K | 389K | 386K | 285K | 437K | -7K | n/a | 118K | 84K | 117K | 117K | -610K | -1.21M | -1.33M |
Change in Working Capital | -10.76M | -13.32M | -10.48M | -13.6M | -12.61M | 48.96M | 40.99M | 46.47M | 50.91M | -5.43M | 19.57M | 20.73M | 21.83M | 24.53M | 3.54M | -1.34M | -4.16M |
Operating Cash Flow | -37.06M | -36.39M | -32.37M | -34.22M | -38.31M | 21.55M | 9.04M | 1.18M | -3.32M | -68.51M | -46.89M | -39.58M | -34.72M | -26.01M | -41.55M | -43.31M | -43.81M |
Capital Expenditures | -905.33K | -1.42M | -4.15M | -4.21M | -4.24M | -3.64M | -756K | -663K | -600K | -708K | -946K | -875K | -696K | -484K | -377K | -466K | -758K |
Cash Acquisitions | n/a | n/a | 12.14K | 12.11K | 12.78K | 59.31K | 52.89K | 52.91K | 52.25K | 5.72K | 59.33K | 59.33K | 59.33K | 59.33K | n/a | n/a | n/a |
Purchase of Investments | 139.89K | -16.96M | -16.96M | -16.96M | -17.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 17M | 17M | 17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -2.8M | -2.8M | 5.46M | 5.46M | 5.6M | 5.6M | 112.31 | 89.89 | 753.41 | 281.41 | 59K | 59K | 59K | 59K | n/a | n/a | n/a |
Investing Cash Flow | 13.44M | -4.07M | 3.71M | -13.34M | -13.37M | 4.28M | -703K | -610K | -547K | -702K | -887K | -816K | -637K | -425K | -377K | -466K | -758K |
Debt Repayment | -1.57M | -1.58M | -2.62M | -2.6M | -2.95M | -2.63M | -1.7M | -45.02M | -44.73M | -45.05M | -18.11M | 25.59M | 26.5M | 26.84M | 442K | 13.75M | 13.44M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 71.76M | 71.86M | 415.33K | 565.33K | 557.33K | 395.33K | 156K | 5K | 1K | 34K | 396K | 798K | 983K | 1.52M | 1.17M | 777K | 835K |
Financial Cash Flow | 70.19M | 70.28M | -2.25M | -2.07M | -2.44M | -2.27M | 12.58M | -30.89M | -30.61M | -30.89M | -17.71M | 49.61M | 133.3M | 136.83M | 110.08M | 99.78M | 16.93M |
Net Cash Flow | 46.7M | 30.48M | -31.15M | -49.59M | -53.27M | 24.15M | 20.12M | -27.84M | -28.63M | -92.75M | -55.71M | 16.96M | 99.73M | 111.69M | 67.29M | 52.3M | -30.18M |
Free Cash Flow | -37.97M | -37.9M | -36.78M | -38.68M | -42.8M | 17.74M | 8.28M | 518K | -3.92M | -69.22M | -47.84M | -40.46M | -35.41M | -26.5M | -41.93M | -43.77M | -44.57M |